BioMimetic (BMTI) Announces Trial for Augment Injectable Bone Graft Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/17/2026

1. JBHT
2. SPY
3. ASML
4. ATAI
5. NVDA
6. JNJ
7. TSM
8. ASML:NA
9. UNH
10. STDN

Go back to BioMimetic (BMTI) Announces Trial for Augment Injectable Bone Graft Met Primary Endpoint